The TGFβ signaling pathway plays a controversial role in CRC tumorigenesis, while in early stages of cancer development, TGFβ displays a tumor suppressor activity, in metastatic CRC TGFβ favors tumor growth, invasion, EMT, metastatic spread, and immune evasion [5–9]. Here, TGFB1 is linked to cancer.